Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.
暂无分享,去创建一个
M. Gladwin | C. Long | L. Leinwand | R. Quaife | D. Gail | R. Barst | M. Mcgoon | N. Voelkel | Yuichiro J Suzuki | D. Meldrum | L. Rubin | Lewis J Rubin | Daniel R Meldrum | J. Dupuis | F. Smart | E. Denholm | Robyn J Barst | Leslie A Leinwand | Jocelyn Dupuis | Michael D McGoon | Norbert F Voelkel | Elizabeth M Denholm | Frank W Smart | Robert A Quaife | Carlin S Long | Yuichiro J. Suzuki | Mark Gladwin | Dorothy B Gail
[1] G. Koch,et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.
[2] D. Cokkinos,et al. Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure. , 1998, The American journal of cardiology.
[3] R. Quaife,et al. The pressure-overloaded right ventricle in pulmonary hypertension. , 1998, Chest.
[4] B. Groves,et al. Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress. , 2006, European journal of medical research.
[5] E. Trulock,et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] P. Pruszczyk. N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction. , 2005, Journal of cardiac failure.
[7] R. Barst,et al. Survival with first-line bosentan in patients with primary pulmonary hypertension , 2005, European Respiratory Journal.
[8] L. Tavazzi,et al. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. , 2000, American heart journal.
[9] R. Speich,et al. Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[10] J B Seward,et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.
[11] J. Dupuis,et al. Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. , 2003, Cardiovascular research.
[12] M. Mcgoon,et al. Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction , 2006 .
[13] M. Hoeper,et al. Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension. , 2001, Chest.
[14] N. Danchin,et al. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. , 1997, European heart journal.
[15] D. Srivastava,et al. The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner , 2004, Development.
[16] M. Barančík,et al. Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. , 2006, General physiology and biophysics.
[17] G. Montalescot,et al. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. , 1998, The American journal of cardiology.
[18] M. Beckerle,et al. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. , 2005, The Journal of clinical investigation.
[19] M. Mehra,et al. Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. , 2004, Congestive heart failure.
[20] J. Sandoval,et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.
[21] T. Bashore,et al. The forgotten chamber: the importance of the right ventricle. , 1995, Catheterization and cardiovascular diagnosis.
[22] Jayant Nath,et al. Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.
[23] A. Taylor,et al. Evolution of resting lung function in the first year after cardiac transplantation. , 1995, The European respiratory journal.
[24] J. Schaper,et al. The role of cell death in heart failure. , 1999, Circulation research.
[25] W. Hopkins. The remarkable right ventricle of patients with Eisenmenger syndrome , 2005, Coronary artery disease.
[26] L. La Vecchia,et al. Left ventricular versus biventricular dysfunction in idiopathic dilated cardiomyopathy. , 1999, The American journal of cardiology.
[27] R. Favaloro,et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] A. Torbicki,et al. Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension , 2003, Circulation.
[29] A J Tajik,et al. Doppler echocardiographic index for assessment of global right ventricular function. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[30] K. Chin,et al. The right ventricle in pulmonary hypertension , 2005, Coronary artery disease.
[31] L. Dušek,et al. Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. , 2003, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[32] R. Levine,et al. Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. , 1998, The American journal of cardiology.
[33] L. Tavazzi,et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.
[34] L. Tavazzi,et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 2000, The American journal of cardiology.
[35] J. Polak,et al. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. , 1983, Journal of the American College of Cardiology.
[36] J. Lewis,et al. Discordance in degree of right and left ventricular dilation in patients with dilated cardiomyopathy: recognition and clinical implications. , 1993, Journal of the American College of Cardiology.
[37] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[38] L. Leinwand,et al. Soy diet worsens heart disease in mice. , 2005, The Journal of clinical investigation.
[39] J. Bronzwaer,et al. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. , 2004, Chest.
[40] M. Wilén,et al. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. , 1984, The American journal of cardiology.
[41] J. Thomas,et al. Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. , 1997, The American journal of cardiology.
[42] D. Green,et al. Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases* , 1999, The Journal of Biological Chemistry.
[43] M. Cleman,et al. The right ventricle in disorders causing pulmonary venous hypertension. , 1992, Cardiology clinics.
[44] J. Mandel. Chapter 6 – Approach to the Patient With Pulmonary Hypertension , 2006 .
[45] V. Aiello,et al. Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. , 2002, The Journal of thoracic and cardiovascular surgery.
[46] B. Conne,et al. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. , 1990, The American journal of pathology.
[47] A. Torbicki,et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.
[48] C. Gross,et al. Pulmonary function after successful heart transplantation. One year follow-up. , 1993, Chest.
[49] H. Bittner,et al. Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. , 1998, Circulation.
[50] E. Trulock,et al. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. , 1991, Journal of the American College of Cardiology.
[51] W. Pu,et al. Morphogenesis of the right ventricle requires myocardial expression of Gata4. , 2005, The Journal of clinical investigation.
[52] M. Cutolo,et al. Successful management of neonatal cryoglobulinaemia after a gemellar pregnancy in a woman with symptomatic type I cryoglobulinaemia , 2004, Annals of the Rheumatic Diseases.
[53] M. B. Perryman,et al. Importance of angiotensin-converting enzyme in pulmonary hypertension. , 1995, Cardiology.
[54] M. Mathier,et al. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. , 1995, Journal of the American College of Cardiology.
[55] S. R. Cohen,et al. Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure. , 1985, Journal of the American College of Cardiology.
[56] D. Berman,et al. Variable spectrum and prognostic implications of left and right ventricular ejection fractions in patients with and without clinical heart failure after acute myocardial infarction. , 1986, The American journal of cardiology.
[57] B. Groves,et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. , 1997, The Journal of clinical investigation.
[58] M. Vogeser,et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[59] A. Waggoner,et al. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. , 2002, The American journal of cardiology.
[60] J. Guerrero,et al. Myocardial perfusion and right ventricular function. , 1999, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[61] K. Kangawa,et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.
[62] B. Gehlbach,et al. The pulmonary manifestations of left heart failure. , 2004, Chest.
[63] E. Dodou,et al. The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. , 2005, Developmental biology.
[64] L. Boxt,et al. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. , 1992, Journal of the American College of Cardiology.
[65] M. Guazzi,et al. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. , 2000, Journal of the American College of Cardiology.
[66] C Berzuini,et al. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[67] P. Krieg,et al. Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF. , 2003, Developmental biology.
[68] B. Brundage,et al. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. , 1995, Circulation.
[69] L. Yap. B-Type Natriuretic Peptide and the Right Heart , 2004, Heart Failure Reviews.
[70] J. Gorcsan,et al. Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome. , 1996, Circulation.
[71] I. Palacios,et al. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. , 1994, American heart journal.
[72] A. Frans,et al. Lung membrane diffusing capacity, heart failure, and heart transplantation. , 1999, The American journal of cardiology.
[73] L. Tavazzi,et al. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. , 2003, American heart journal.
[74] B Wranne,et al. Normal regional right ventricular function and its change with age: a Doppler myocardial imaging study. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[75] C. R. Smith,et al. Variability of right ventricular functional recovery after lung transplantation. , 1996, Transplantation.
[76] A. Baker,et al. Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. , 2006, American journal of physiology. Heart and circulatory physiology.
[77] J. Seward,et al. Relation of tissue displacement and strain to invasively determined right ventricular stroke volume. , 2005, The American journal of cardiology.
[78] W. Kuebler,et al. The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo , 2003, Intensive Care Medicine.
[79] D. Srivastava,et al. The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. , 1998, Developmental biology.
[80] Ladislav Dusek,et al. Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[81] J. Molkentin,et al. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene , 1994, Molecular and cellular biology.
[82] I. Dimopoulou,et al. Effects of severity of long-standing congestive heart failure on pulmonary function. , 1998, Respiratory medicine.
[83] M. Buckingham,et al. Right Ventricular Myocardium Derives From the Anterior Heart Field , 2004, Circulation research.
[84] C. Greyson,et al. Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload. , 2000, American journal of physiology. Heart and circulatory physiology.
[85] B. Groves,et al. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics , 2003, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[86] X Marchandise,et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. , 1998, Journal of the American College of Cardiology.
[87] John McAnally,et al. BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart , 2005, Development.
[88] K. Maehara,et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. , 1998, Circulation.
[89] I. Starr,et al. The absence of conspicuous increments of venous pressure after severe damage to the right ventricle of the dog, with a discussion of the relation between clinical congestive failure and heart disease , 1943 .
[90] A. Harmar,et al. Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease , 2005, Circulation research.
[91] R. Bansal,et al. Determinants of the rate of right ventricular pressure rise by Doppler echocardiography: potential value in the assessment of right ventricular function. , 1994, The Journal of heart valve disease.
[92] D. Mccrory,et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.